Medtech 360

Introduction:

The global breast biopsy device market will expand and shift through 2017 due to the growing population at risk of developing breast cancer and because of increasing compliance to breast cancer screening programs.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for breast biopsy devices in the US, France, Germany, Italy, the UK, Japan, and China, with market projections 5 years into the future.

We have up-to-date reports on a wide range of medical device markets worldwide.

Questions Answered in This Report:

  *   The number of competitors participating in the VAB device market is low despite its size. The competitive landscape of this market has changed vastly since 2010 due to a number of company and product acquisitions that year.

How did these acquisitions impact the dynamics of the VAB device market?

Who was the VAB device market leader in 2012, and what contributed to its success?

What barriers are preventing new competitors from entering this lucrative market?

  *   The number of breast biopsies that are performed using imaging guidance is increasing. Newer and more sophisticated breast imaging systems are being developed and released.

What is driving the rising popularity of certain modalities in image-guided breast biopsy?

How do the preferences for and use of image-guided breast biopsy differ across regions?

How will these advanced imaging systems affect the breast biopsy device market?

  *   The fine needle market will continue to remain the smallest segment in the global breast biopsy device market through the forecast period.

What is driving the shift to CNB and VAB?

How much faster are the CNB and VAB device markets growing, and how does the growth differ across regions?

What is sustaining the use of FNA in certain regions?

Scope:

Geographies Covered: US, France, Germany, Italy, UK, Japan, and China

Procedures Covered: Our analysis uses the following breakdown of procedures:

Source: Millennium Research Group
Technique
Minimally Invasive
	Procedure Type
	VAB
	CNB
	FNA
	Modality
	Ultrasound
	Stereotactic Mammography
	MRI
Open Surgical

Products Covered: Our analysis uses the following breakdown of products in the market:

Product Type
VAB Devices	Product Type
	Capital Equipment
	Disposable Devices
	VAB Markers
CNB Devices	Product Type
	Fully Disposable Devices*
	Disposable Needles**
	CNB Markers
Fine Needles
Notes: *Fully disposable CNB devices include both the gun and needle. **Disposable needles consist of those used with reusable guns. Reusable guns are not included in the market model because the devices are typically offered to facilities at no cost in exchange for disposables contracts.
Source: Millennium Research Group

Market Forecast Features: Based on primary research with industry professionals, we use our proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 7-year period (2011–2017).

Competitive Analysis: We provide a detailed analysis of the competitive landscape and market shares for leading competitors.

Authors:

Michelle Chan

Contributors
April Chan
Steven Edgar, M.A.
Karen Gierszewski
Samuli Heilala, M.Sc.
Nancy Huynh